Sorry!! The article you are trying to read is not available now.

Goldman Sachs Beats Earnings, Mosaic, TDAmeritrade Boost Dividends

Print comment Post Comments
Mosaic (MOS) earnings per share of $1.19 beat the expected $1.17, but declined 21.1% from a year ago. Quarterly revenue of $2.82 billion also topped estimates but declined 1.4% from last year. MOS boosted their quarterly dividend from 12.5c to 25c, with analysts not expecting any change. Shares traded 3% higher on the news.

Goldman Sachs (GS) reported earnings per share of $1.78, crushing the expected $1.18. Second quarter revenue also beat expectations by a considerable margin, coming in at $6.63 billion versus the consensus $6.25 billion. Investment management revenue rose 5% on the quarter. Operating expenses were also down 23% for the quarter. Shares traded over $100 for the first time since May on the news.

TD Ameritrade (AMTD) beat street EPS estimates, reporting 28c a share against the 26c that was expected. The reported $667 million in revenue was slightly higher than the $665.6 million that was expected. The company reported a dividend of 6c/share, payable at the end of July. Average client trades per day was 355,449, down 4% Y/Y and down 8.3% Q/Q. Shares traded 3% higher in pre-market on the news.

Coca-Cola (KO) beat both revenue and earnings per share estimates. EPS came in at $1.22, a 3c per share beat. Revenue came in at $13.09 billion, topping the expected $12.8 billion. The strength of the dollar was estimated to have had an 8-9% negative impact on revenue. Commodity prices also negatively contributed to about $300m in revenues. International volume grew 5% both this quarter and year to year. Shares edged slightly higher pre-market.

State Street (STT) reported earnings per share and revenue that came in line with expectations but declined year on year. Second quarter earnings per share was 98c a share, exactly what was expected. The reported revenue of $2.42 billion was also exactly what was expected.

Johnson & Johnson (JNJ) slightly beat EPS estimates, reporting $1.30 a share versus the $1.29 expected. Quarterly revenue fell short of estimates, coming in at just $16.48 billion versus the $16.70 billion expected. The company noted a negative effect of currency movements to the tune of 7.5% (the higher dollar), and revenues reflected a $2.2b writedown on vaccines. The company lowered guidance for the year on negative currency movements.

Shares traded down 1.25% on the news.

Follow the markets all day every day with a FREE 14 day trial to Buzz & Banter. Over 30 professional traders share their ideas in real-time. Learn more.
POSITION:  No positions in stocks mentioned.